The Application of Dupilumab to Pediatric Patients Aged 6–11yrs with Moderate-to-Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled: The Clinical Data so Far

Balboul S, Kahn J, Tracy A, Peacock A, Cline A

Drug Design, Development and Therapy 2023, 17:1323-1327

Published Date: 1 May 2023